Cardinal Health Inc (CAH) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Cardinal Health Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries
the bull case· 4
5
customers naming the company as a supplier in their own filings
sec filingsfrom their filings26.00%
share of Gilead Sciences revenue supplied by the company
10-Kfrom their filing+8.65%
change in shares held by the ten largest reporting managers
13fJun 30 '2610
funds on file reporting a position in the company
n-portas of Jun 30 '26the bear case· 4
30.00%
revenue concentrated with the largest disclosed customer CVS Health Corporation
10-Kfiled Aug 12 '2510 of 21
largest reporting managers cutting their stake in the latest quarter
13fJun 30 '264 of 8
recent reports with moves under the options implied range
earnings historyimplied vs realized63
managers whose positions together make up four fifths of reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 3 '26 report. Not a forecast, not advice.
Of the 6 companies Cardinal Health Inc moves with most closely, 2 also share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries, from each company's own filings. Largest first.
A rule beside a ticker marks a company that appears in both readings.
Which of these the filings never mention ›High 226.02 at 6:00 am ET, low 222.72 at 9:30 am ET.
CAH (Cardinal Health Inc) has 11 disclosed suppliers and 9 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
tall tick = annual report · 1 on record
1,503 managers report a position worth $49.7B between them, and 63 of them hold 80% of it.